CCR2 deficiency upregulates IL-4, IL-5, and Th2 transcription factors during <i>C</i>. <i>muridarum</i> infection. by Shuaini Yang (20670608)

Subjects:

CCR2 deficiency elevates <i>C</i>. <i>muridarum</i>-induced Th17-type immune response. by Shuaini Yang (20670608)

Subjects:

CCR2 deficiency attenuates the infiltration of myeloid cells and diminishes the numbers and activation of T cells following <i>C</i>. <i>muridarum</i> respiratory infection. by Shuaini Yang (20670608)

Subjects:

Th1 differentiation and IFN-γ secretion are impaired in <i>ccr2</i>^-/- mice during <i>C</i>. <i>muridarum</i> infection. by Shuaini Yang (20670608)

Subjects:

Reduced resistance and exacerbated lung inflammation in <i>ccr2</i>^-/- mice with <i>C</i>. <i>muridarum</i> respiratory infection. by Shuaini Yang (20670608)

Subjects:

Analysis of the Nugent score before (T=0) and after (T=1) the use of the vaginal gel. Number of participants and respective percentages of Nugent scores before and after the intervention. A statistically significant decrease in Nugent scores was observed after the intervention (p value =0.0047). by Adriana Bittencourt Campaner (21175462)

“…Number of participants and respective percentages of Nugent scores before and after the intervention. A statistically significant decrease in Nugent scores was observed after the intervention (p value =0.0047).…”

Descriptive statistics of alcohol consumption in G7 countries (in litres/capita). by Luis Alberiko Gil-Alana (14659817)

Subjects:

Data for the G7 countries in 2022. by Luis Alberiko Gil-Alana (14659817)

Subjects:

Estimates of the differencing parameter, d, in Eq (1). by Luis Alberiko Gil-Alana (14659817)

Subjects:

Estimates of the differencing parameter, d, in Eq (1). by Luis Alberiko Gil-Alana (14659817)

Subjects:

Time series plots: Alcohol consumption. by Luis Alberiko Gil-Alana (14659817)

Subjects:

Estimated coefficients based on the selected model in Table 4. by Luis Alberiko Gil-Alana (14659817)

Subjects:

Estimated coefficients based on the selected model in Table 3. by Luis Alberiko Gil-Alana (14659817)

Subjects:

Trends of incident opioid users, L-TOT users, and L-TOT discontinuers between 2009 and 2013. by Qian Cai (112039)

Subjects:

The yearly numerator, denominator and rate of incident opioid users, L-TOT users and L-TOT discontinuers from 2009 to 2019. by Qian Cai (112039)

Subjects:

Incidence rate ratios of negative binominal regression models for yearly rates of incident opioid users, L-TOT users and L-TOT discontinuers during 2009–2013 and 2015–2019. by Qian Cai (112039)

Subjects:

Demographic, comorbidity, concurrent drug, and opioid characteristics, among L-TOT users and L-TOT discontinuers between 2009–2019. by Qian Cai (112039)

Subjects:

Basic characteristics of the studies included. by Renáta Kiss-Miki (20760127)

Subjects:

PRISMA flowchart of the article selection process. by Renáta Kiss-Miki (20760127)

Subjects:

List_of_studies_identified_31-JAN-2025. by Renáta Kiss-Miki (20760127)

Subjects: